Vancouver, Canada

Richard Ting



Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Richard Ting in Imaging Agents

Introduction

Richard Ting is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of imaging agents, particularly in the development of novel compounds for medical applications. With a total of 2 patents, his work has the potential to enhance diagnostic imaging techniques.

Latest Patents

Richard Ting's latest patents include "Substituted aryl-fluoroborates as imaging agents" and "Radiolabeled compounds and compositions, their precursors and methods for their production." The first patent focuses on substituted aryl-boron compounds that serve as positron emission tomography (PET) imaging agents. These compounds are designed to improve imaging quality by incorporating electron-withdrawing groups in specific positions on the aromatic ring. The second patent outlines methods for producing positron-emitting compounds, which are crucial for advanced imaging techniques.

Career Highlights

Richard Ting is affiliated with the University of British Columbia, where he continues to push the boundaries of research in imaging technology. His innovative work has garnered attention in the scientific community, contributing to advancements in medical diagnostics.

Collaborations

Richard has collaborated with notable colleagues such as David Perrin and Christopher Overall, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Richard Ting's contributions to the field of imaging agents exemplify the importance of innovation in medical technology. His patents and ongoing research hold promise for improving diagnostic capabilities in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…